글로벌 생물학적 완충액 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2035년까지의 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Healthcare Global Biological Buffers Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 무료 샘플 보고서 무료 샘플 보고서 구매하기 전에 문의 구매하기 전에 문의 지금 구매 지금 구매

글로벌 생물학적 완충액 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2035년까지의 예측

  • Healthcare
  • Published Report
  • Apr 2025
  • Global
  • 350 Pages
  • 테이블 수: 861
  • 그림 수: 38
  • Author : Sachin Pawar
지금 구매 지금 구매 샘플요청 샘플요청
Nucleus Nucleus

민첩한 공급망 컨설팅으로 관세 문제를 극복하세요

공급망 생태계 분석이 이제 DBMR 보고서의 일부가 되었습니다

Global Biological Buffers Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Chart Image USD 1,850.91 Million USD 837.07 Million 2024 2035
Diagram 예측 기간
 2025 –2035
Diagram 시장 규모(기준 연도)
 USD 1,850.91 Million
Diagram 시장 규모(예측 연도)
 USD 837.07 Million
Diagram 연평균 성장률
 %
Diagram 주요 시장 플레이어
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc.
  • Merck KGaA

글로벌 생물학적 완충액 시장 세분화, 완충액 유형(제품 완충액 및 기타 염 기반 완충액), 제형(분말 및 액상), 응용 분야(제약 및 생물약학, 세포 배양 및 분자 생물학, 임상 및 진단 응용 분야, 화학 및 산업 응용 분야, 기타), 최종 사용자(제약 및 생물약학 회사, 생명공학 회사, 연구 및 학술 기관, 진단 실험실, 임상시험수탁기관(CRO) 및 CMO) - 2035년까지의 산업 동향 및 전망

생물학적 완충제 시장

생물학적 완충액 시장 분석 및 규모

글로벌 생물학적 완충액 시장은 실험실 및 생물의학 환경에서 안정적인 pH 환경을 유지하는 데 사용되는 약산과 그 짝염기(또는 약염기와 그 짝산)를 포함하는 용액인 생물학적 완충액의 생산, 유통 및 판매에 중점을 둔 시장을 의미합니다. 이 시장은 인산염 완충액, 트리스 완충액, HEPES 완충액 등 다양한 생물학적 완충액을 포괄하며, 생명과학 연구, 생명공학, 제약, 진단 등 다양한 분야의 응용 분야에 활용됩니다.

생물학적 완충제 시장생물학적 완충제 시장

생물학적 완충제 시장 규모

Data Bridge Market Research에 따르면, 글로벌 생물학적 완충액 시장은 2024년 8억 3,707만 달러에서 2035년 18억 5,091만 달러로 성장할 것으로 예상되며, 2025년부터 2035년까지 예측 기간 동안 7.5%의 높은 CAGR로 성장할 것으로 전망됩니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 기업 등 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 수입/수출 분석, 가격 분석, 생산 소비 분석, PESTLE 분석이 포함되어 있습니다.

생물학적 완충제 시장 동향

“AI 기반 기술 도입 증가”

생물학적 완충 시장은 AI 기반 솔루션으로의 상당한 전환을 경험하고 있습니다. 실험실과 바이오 제약 회사들이 정밀성, 효율성, 그리고 규제 준수를 중시함에 따라, 인공지능과 머신러닝이 완충액 제형 및 품질 관리 프로세스에 통합되고 있습니다. 이러한 기술은 pH 안정화 최적화, 완충액 성능 예측 향상, 그리고 생산 워크플로우 간소화에 기여합니다. 또한, 약물 개발, 임상 연구, 바이오 프로세싱 등의 분야에서 실시간 모니터링 및 자동화된 조정에 대한 요구가 증가함에 따라 수요도 증가하고 있습니다. 규제 기준이 강화되고 디지털 전환이 가속화됨에 따라, AI 기반 생물학적 완충 솔루션은 업계 표준으로 자리 잡을 것으로 예상됩니다.

보고서 범위 및 생물학적 완충액 시장 세분화

속성

생물학적 완충액 주요 시장 통찰력

다루는 세그먼트
  • 버퍼 유형: 상품 버퍼 및 기타 소금 기반 버퍼
  • 제형: 분말 및 액상
  • 응용 분야: 제약 및 생물제약, 세포 배양 및 분자 생물학, 임상 및 진단 응용 분야, 화학 및 산업 응용 분야, 기타
  • 최종 사용자: 제약 및 생물제약 회사, 생명공학 회사, 연구 및 학술 기관, 진단 실험실, 계약 연구 기관(CRO) 및 CMO

포함 국가

미국, 캐나다, 멕시코, 독일, 영국, 프랑스, ​​이탈리아, 스페인, 러시아, 네덜란드, 스위스, 터키, 오스트리아, 폴란드, 아일랜드, 노르웨이, 유럽 기타 지역, 일본, 중국, 한국, 인도, 싱가포르, 태국, 인도네시아, 말레이시아, 필리핀, 호주, 뉴질랜드, 대만, 아시아 태평양 기타 지역, 브라질, 아르헨티나, 칠레, 페루, 남미 기타 지역, 남아프리카 공화국, 사우디아라비아, UAE, 이집트, 쿠웨이트, 이스라엘, 중동 및 아프리카 기타 지역

주요 시장 참여자

F. Hoffmann-La Roche Ltd(스위스), Bio-Rad Laboratories, Inc.(미국), Thermo Fisher Scientific Inc.(미국), Takara Bio Inc.(일본), Merck KGaA(독일) 등

시장 기회
  • 생물의학 연구에 대한 공공-민간 자금 지원 증가
  • 식품 안전 및 환경 시험을 위한 분석 방법

부가가치 데이터 정보 세트

Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체 등 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 수입/수출 분석, 가격 분석, 생산 소비 분석, PESTLE 분석이 포함되어 있습니다.

생물학적 완충제 시장 정의

생물학적 완충액은 약산과 그 짝염기(또는 약염기와 그 짝산)를 포함하는 용액으로, 산이나 염기를 첨가해도 pH 변화에 강합니다. 효소와 기타 생체 분자는 pH 변화에 매우 민감하기 때문에 생물학적 시스템 및 실험실 환경에서 안정적인 pH 환경을 유지하는 데 생물학적 완충액은 필수적입니다. 일반적인 생물학적 완충액으로는 인산염, 트리스, HEPES가 있으며, 각각은 다양한 용도에 적합한 특정 완충 범위를 가지고 있습니다.

글로벌 생물학적 완충액 시장 동향

이 섹션에서는 시장 동인, 이점, 기회, 제약, 그리고 과제를 이해하는 데 중점을 둡니다. 이 모든 내용은 아래와 같이 자세히 논의됩니다.

운전자

  • 만성 질환의 유병률 증가

당뇨병, 암, 심혈관 질환 등 만성 질환의 유병률 증가는 전 세계 생물학적 완충액 시장의 주요 성장 동력입니다. 이러한 증가는 질병 메커니즘을 이해하고, 진단 도구를 개발하고, 효과적인 치료법을 수립하기 위한 연구 개발 노력을 더욱 강화해야 함을 의미합니다. 생물학적 완충액은 세포 배양, 신약 개발, 단백질 분석을 포함한 다양한 분야에서 정확한 실험 및 분석에 필수적인 안정적인 pH 환경을 제공하기 때문에 이러한 노력에 중요한 역할을 합니다.

예를 들어,

  • 2024년 1월 NCBI에 발표된 논문에 따르면, 당뇨병, 심장병, 뇌졸중, 암과 같은 만성 질환은 오랫동안 전 세계 이환율과 사망률에 중요한 영향을 미쳐 왔으며, 앞으로도 계속 그럴 것으로 예상됩니다. 이러한 질병은 수백만 명의 생명에 영향을 미칠 뿐만 아니라 전 세계 의료 시스템에 상당한 부담을 가하고 있습니다. 만성 질환 관리에 따른 재정적 영향은 급격히 증가할 것으로 예상되며, 2030년까지 전 세계적으로 약 47조 달러에 달할 것으로 추산됩니다. 이 놀라운 수치는 지속적인 치료, 첨단 치료법, 그리고 광범위한 의료 자원을 필요로 하는 만성 질환의 부담이 커지고 있음을 보여줍니다.
  • WHO가 발표한 자료에 따르면 2024년 7월 기준, 2023년 말 HIV 감염자는 약 3,990만 명(3,610만~4,460만 명)으로 추산되며, 이 중 140만 명(110만~170만 명)의 어린이(0~14세)와 3,860만 명(3,490만~4,310만 명)의 성인(15세 이상)이 HIV에 감염되었습니다. 2023년에는 130만 명(100만~170만 명)이 HIV에 감염되었습니다. 2023년에는 12만 명(8만 3천~17만 명)의 어린이가 HIV에 감염되었습니다. 2023년에는 120만 명(95만~150만 명)의 성인이 HIV에 감염되었습니다.

이러한 질병의 유병률은 지역에 따라 다르며, 농촌 지역 노인의 약 17%, 도시 지역 노인의 약 29%가 만성 질환을 앓고 있습니다. 이러한 질환 중 고혈압과 당뇨병은 특히 흔하며, 노인 인구의 전체 만성 질환의 약 68%를 차지합니다. 이는 인도 고령 인구의 만성 질환 부담 증가에 대응하기 위한 집중적인 의료 개입과 관리 전략의 시급성을 보여줍니다.

  • Western BLOT 및 Elisa 기술의 채택 증가

웨스턴 블롯과 엘리사 기술은 생명과학 연구 및 진단에 있어 핵심적인 기술로, 단백질 및 기타 생체 분자의 검출 및 정량화를 가능하게 합니다. 특히 신약 개발, 질병 진단, 바이오마커 식별 등의 분야에서 연구 활동이 확대됨에 따라 이러한 기술에 대한 수요도 증가하고 있으며, 결과적으로 최적의 분석 성능에 필수적인 고품질의 신뢰할 수 있는 완충액에 대한 필요성이 커지고 있습니다.

예를 들어,

  • 2023년 4월, 미국 국립의학도서관(National Library of Medicine)에 게재된 논문에 따르면, 이 논문은 생물학적 물질의 검출 및 정량 분석에 있어 다재다능함, 민감도, 그리고 특이성을 갖춘 ELISA(효소연계면역흡착검사)의 사용 증가를 강조하고 있습니다. 이러한 사용 증가는 의료 진단, 식품 안전, 그리고 연구 분야 전반에 걸친 ELISA의 적용 가능성에 기인합니다. ELISA는 광범위한 항원과 항체를 검출할 수 있는 능력과 자동화 및 다중화 기술의 발전으로 임상 및 검사실 환경 모두에서 선호되는 검사법입니다. ELISA의 간편성, 재현성, 그리고 비용 효율성은 ELISA의 사용 증가에 더욱 기여하고 있습니다.
  • 2021년 4월 IUBMB 저널에 게재된 논문에 따르면, 웨스턴 블롯(Western Blot, WB)은 생물학자들이 단백질 생체 분자의 다양한 측면을 연구하는 데 자주 사용하는 기본적인 방법입니다. 연구 외에도 단백질을 직접 검출할 수 있어 질병 진단에 널리 활용되고 있으며, 임상 현장에서 일상적으로 사용되는 매우 효과적인 진단 도구입니다. 웨스턴 블롯의 다재다능함과 신뢰성 덕분에 생물학 실험실에서 널리 채택되어 연구 및 임상 적용 모두에 필수적인 기술 중 하나로 자리매김했습니다.

생물학적 완충제 시장

기회

  • 생물의학 연구에 대한 공공-민간 자금 지원 증가

과학 연구 개발에 더 많은 재정 자원이 할당됨에 따라, 기업들은 블로킹 버퍼 성능을 향상시키는 혁신적인 제형과 기술에 투자할 잠재력을 가지고 있습니다. 이 자금은 특정 용도에 맞춰진 맞춤형 솔루션 개발을 지원하여 분석의 특이성을 높이고 배경 잡음을 줄입니다. 또한, 연구 기관과의 협력을 촉진하여 버퍼 기술의 획기적인 발전을 이룹니다. 투자 증가는 친환경적이고 지속 가능한 제품 개발을 촉진하여 친환경 솔루션에 대한 소비자 수요 증가에 발맞춥니다. 전반적으로, 이러한 자금 조달 추세를 활용함으로써 블로킹 버퍼 시장의 발전을 촉진하고 빠르게 변화하는 환경에서 경쟁 우위를 확보할 수 있습니다.

예를 들어,

  • 2021년 5월 NCBI에 게재된 논문에 따르면, 생의학 연구에 대한 공공-민간 자금 지원이 급증하고, 웨스턴 블롯 기술의 적용이 증가하고 제품 혁신이 증가하면서 성장에 유리한 환경이 조성되었습니다. 이러한 추세는 블로킹 버퍼 시장이 확장하고 발전할 수 있는 중요한 기회로 작용합니다.
  • 2024년 6월, iScience에 게재된 논문에 따르면, 게놈 편집 분야, 특히 미국에서는 공공-민간 파트너십(PP)이 활발하게 진행되고 있습니다. 과학자들은 민간 부문의 분사 및 자문 역할 등 다양한 역할을 수행하고 있습니다. 이러한 협력 생태계는 혁신과 자원 공유를 촉진하여 블로킹 버퍼 시장이 확장하고 적응할 수 있는 중요한 기회를 창출합니다.
  • 2023년 3월, NCBI에 발표된 논문에 따르면 국제 생의학 과학자 연합인 Target 2035는 개방형 원칙을 활용하여 건강과 질병 연구에 필수적인 모든 인간 단백질에 대한 약리학적 도구를 개발하고 있습니다. 제약 회사들이 지식과 ​​시약을 제공함에 따라, 이 이니셔티브는 블로킹 버퍼 시장의 성장과 혁신을 위한 귀중한 기회를 제공합니다.

최근 공공-민간 자금 지원 급증은 블로킹 버퍼 시장에 상당한 기회를 제공합니다. 과학 연구에 대한 재정 지원 증가는 기업들이 버퍼 성능을 향상시키는 혁신적인 제형에 투자할 수 있도록 합니다. 이러한 자금 지원은 맞춤형 솔루션 개발을 촉진하고, 특정 제품의 특성을 강화하며, 연구 기관과의 협력을 촉진하여 궁극적으로 친환경 제품을 개발하는 데 기여합니다. 이러한 추세는 블로킹 버퍼 시장의 상당한 성장을 가능하게 합니다.

  • 식품 안전 및 환경 시험을 위한 분석 방법

식품 안전 및 환경 시험과 같은 산업은 정밀 분석 방법에 점점 더 의존하고 있으며, 고품질 블로킹 버퍼는 배경 잡음을 최소화하고 분석 감도를 향상시키는 데 중요한 역할을 합니다. 규제 기준이 더욱 엄격해짐에 따라 이러한 분야에서 효과적인 블로킹 솔루션에 대한 수요가 증가할 것으로 예상됩니다. 식품 안전 시험(알레르겐 검출 및 병원균 식별 등)과 환경 모니터링(오염 물질 분석 등)의 고유한 요건에 맞춰 개발된 특수 버퍼를 통해 제조업체는 성장하는 시장에 진출할 수 있습니다. 이러한 맞춤형 접근 방식은 특정 산업의 요구를 충족할 뿐만 아니라 경쟁 우위를 확보하는 데에도 도움이 됩니다. 이러한 틈새 시장에 맞춤형 솔루션을 혁신하고 제공하는 기업은 더 넓은 블로킹 버퍼 시장에서 상당한 성장을 이룰 수 있습니다.

예를 들어,

  • 2021년 9월 Springer Nature에 게재된 논문에 따르면, 식품 분석에서 효소 결합 면역흡착 분석법(ELISA)의 활용은 블로킹 완충액 시장에 중요한 기회를 제공합니다. ELISA의 민감도와 특이도는 살충제와 독소를 포함한 다양한 성분의 검출을 가능하게 합니다. 이러한 다재다능함은 식품 안전 분야에 특화된 특수 블로킹 완충액에 대한 귀중한 기회를 제공합니다.
  • 2020년 5월, Science Direct에 게재된 논문에 따르면 식품 내 화학 물질 오염의 만연은 블로킹 버퍼 시장에 중요한 기회를 제공합니다. 경쟁력 있는 효소면역측정법(Cp-ELISA)은 높은 처리량과 저렴한 비용으로 이러한 오염 물질 검출에 널리 사용되고 있으며, 분석 성능 향상을 위한 효과적인 블로킹 버퍼의 필요성을 강조합니다.
  • 2020년 2월 Springer Nature에 게재된 논문에 따르면, 효소면역측정법(ELISA)을 이용한 수생 환경 내 의약품 모니터링은 차단 완충액 시장에 귀중한 기회를 제공합니다. 오염물질의 정확한 검출에 대한 수요가 증가함에 따라, 환경 시험에서 분석 감도와 신뢰성을 향상시키기 위해 효과적인 차단 완충액이 필수적입니다.

고령 인구 증가는 전 세계 생물학적 완충액 시장의 주요 성장 동력입니다. 고령자는 각막 손상 및 이식 수술 필요성으로 이어질 수 있는 다양한 안구 질환에 더 취약하기 때문입니다. 푹스 내피 이영양증, 수포성 각막병증, 기타 퇴행성 각막 질환과 같은 연령 관련 안구 질환은 고령화와 함께 더욱 흔해지면서 생물학적 완충액에 대한 수요가 크게 증가합니다. 또한, 고령자는 백내장 수술 합병증을 겪거나 당뇨병과 같은 만성 질환을 앓을 가능성이 더 높으며, 이는 각막 악화에 더욱 기여할 수 있습니다. 전 세계 인구 고령화에 따라 생물학적 완충액이 필요한 사람의 수는 증가할 것으로 예상되며, 특히 인구 고령화가 빠르게 진행되는 지역에서 더욱 증가할 것으로 예상됩니다. 이러한 추세는 생물학적 완충액의 가용성 및 성공률에 대한 인식 증가와 고령 환자에게 더 나은 결과와 빠른 회복 시간을 제공하는 수술 기술의 발전으로 더욱 가속화되고 있습니다. 그 결과, 노령 인구의 증가는 글로벌 생물학적 완충액 시장 확대를 촉진하는 주요 요인이 되었으며, 연령 관련 각막 질환에 대한 접근 가능하고 효과적인 치료 옵션에 대한 필요성이 부각되었습니다.

제지/도전

  • 생물학적 완충액 억제를 위한 대체 기술 및 접근 방식

생물학적 완충액 시장은 기존의 차단 완충액 없이도 정밀한 상호작용을 가능하게 하는 무표지 검출 및 미세유체역학과 같은 대체 방법론과 첨단 기술의 등장으로 상당한 어려움에 직면하고 있습니다. 이러한 기술은 배경 잡음을 줄여줍니다. 다중화(multiplexing)를 포함한 면역 분석법의 혁신은 특이성을 향상시키고 기존 차단 전략에 대한 의존도를 더욱 낮춥니다. 더욱이, 표적 결합을 위한 나노기술의 적용은 생물학적 완충액의 기존 역할을 더욱 복잡하게 만듭니다. 이러한 대안들이 비용 효율적인 솔루션을 제공하며 주목을 받으면서, 민감한 분석에서 배경 잡음을 발생시켜 이중적인 어려움을 야기할 수 있습니다. 이러한 방법들이 연구 및 임상 분야에서 더욱 널리 수용됨에 따라, 시장은 혁신과 적응에 대한 압박을 받고 있으며, 이는 수요를 변화시키고 경쟁 환경을 변화시킬 수 있습니다.

예를 들어,

  • 2021년 7월 Springer Nature Limited에 게재된 논문에 따르면, 세포 무함유 유전자 발현(CFE)은 구조 생물학 및 단백질체학 분야에서 단백질 합성 및 표지를 위한 기존의 세포 기반 방법에 대한 대안을 제시합니다. 이 혁신적인 접근법은 특이성을 향상시키고 비특이적 상호작용을 줄여, 더 효율적인 방법론에 대한 수요가 증가함에 따라 블로킹 버퍼 시장에서 난제로 떠오르고 있습니다.
  • 2024년 3월 MDPI에 게재된 논문에 따르면, 비특이적 상호작용을 억제하도록 설계된 pHPMA 또는 폴리(2-옥사졸린) 기반 완전 합성 공중합체가 합성되었습니다. 이러한 공중합체는 진단 검사에서 BSA 또는 기타 단백질을 대체할 수 있는 잠재적인 후보 물질로 작용할 수 있으며, 이는 블로킹 완충액 시장에서 상당한 난제를 야기할 수 있습니다.
  • 2023년 8월 MDPI에 게재된 논문에 따르면, 겔 제조를 간소화하고, 전기영동 완충액을 최적화하며, 안전성을 높이기 위해 메탄올을 에탄올로 대체하여 면역블로팅 공정을 개선했습니다. 이러한 개선을 통해 효율이 거의 4배 향상되어 저품질 항체도 효과적으로 시각화할 수 있습니다. 이러한 혁신은 블로킹 완충액 시장에서 새로운 도전 과제를 제시합니다.

생물학적 완충제 시장 범위

글로벌 생물학적 완충액 시장은 완충액 유형, 제형, 용도 및 최종 사용자를 기준으로 네 가지 주요 세그먼트로 구분됩니다. 이러한 세그먼트의 성장은 업계 내 저조한 성장 세그먼트를 분석하고, 사용자에게 핵심 시장 용도를 파악하기 위한 전략적 의사 결정에 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공합니다.

버퍼 유형

  • 상품 버퍼
    • 트리스 버퍼
      • 트리스(트리스(하이드록시메틸)아미노메탄)
      • 트리스 NA
      • 트리스-HCL
    • 헤페스 버퍼
      • 헤페스
      • 헤페스 NA
    • 걸레 버퍼
      • 걸레
      • 걸레 NA
    • 메스 버퍼
      • 메스
      • 메스 나
    • 비스-트리스 버퍼
      • 비스-트리스
      • 비스-트리스 HCL
    • 기타
  • 기타 소금 기반 완충액
    • 인산염 완충액
      • 인산염 완충 식염수(PBS)
      • 인산나트륨
      • 인산칼륨
    • 아세테이트 완충액
      • 아세트산나트륨
      • 아세트산칼륨
    • 시트르산 완충액
      • 구연산나트륨
      • 구연산
    • 아미노산 완충액
      • 글리신 완충액
      • 히스티딘 완충액

공식화

  • 가루
  • 액체

애플리케이션

  • 제약 및 바이오제약
    • 약물 개발
    • 백신 제형
    • 생물학 제조
  • 세포 배양 및 분자 생물학
    • PCR 및 전기영동
    • 세포 배양 배지 준비
    • DNA 및 RNA 분리
    • 단백질 정제
  • 임상 및 진단 응용 프로그램
    • 체외진단(IVD)
    • 임상 테스트 키트
  • 화학 및 산업 응용 분야
    • 생명공학 연구
    • 식품 및 음료 가공
  • 기타

최종 사용자

  • 제약 및 바이오 제약 회사
  • 생명공학 회사
  • 연구 및 학술 기관
  • 진단 실험실
  • 계약 연구 기관(CROS) 및 CMOS

생물학적 완충제 시장

생물학적 완충제 시장 지역 분석

생물학적 완충액 시장을 분석하고, 완충액 유형, 제형, 응용 분야 및 최종 사용자를 기반으로 시장 규모에 대한 통찰력과 추세를 제공합니다.

이 시장 보고서에서 다루는 국가는 미국, 캐나다, 멕시코, 독일, 영국, 프랑스, ​​이탈리아, 스페인, 러시아, 네덜란드, 스위스, 터키, 오스트리아, 폴란드, 아일랜드, 노르웨이, 기타 유럽 국가, 일본, 중국, 한국, 인도, 싱가포르, 태국, 인도네시아, 말레이시아, 필리핀, 호주, 뉴질랜드, 대만, 기타 아시아 태평양 국가, 브라질, 아르헨티나, 칠레, 페루, 기타 남미 국가, 남아프리카 공화국, 사우디 아라비아, UAE, 이집트, 쿠웨이트, 이스라엘, 기타 중동 및 아프리카 국가입니다.

북미는 높은 연구개발비 지출, 주요 시장 참여자의 존재, 선진 인프라, 강력한 의료 시스템, 엄격한 규제 등으로 인해 시장을 지배할 것으로 예상됩니다.

아시아 태평양 지역은 의료비 지출 증가, 개발 중인 의료 인프라와 유병률 증가에 따른 제약 산업의 확대로 인해 가장 빠르게 성장하는 시장이 될 것으로 예상됩니다.

보고서의 국가별 섹션은 현재 및 미래 시장 동향에 영향을 미치는 개별 시장 영향 요인과 시장 규제 변화도 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 동향, 포터의 5대 경쟁 요인 분석, 사례 연구 등의 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 활용됩니다. 또한, 글로벌 브랜드의 존재 및 가용성, 그리고 국내 및 국내 브랜드와의 경쟁이 심화되거나 부족해짐에 따라 직면하는 과제, 국내 관세 및 무역 경로의 영향 등을 고려하여 국가별 데이터를 예측 분석합니다.

생물학적 완충제 시장

글로벌 생물학적 완충액 시장 점유율

시장 경쟁 구도는 경쟁사별 세부 정보를 제공합니다. 여기에는 회사 개요, 회사 재무 상태, 매출 창출, 시장 잠재력, 연구 개발 투자, 신규 시장 진출, 글로벌 입지, 생산 시설 및 설비, 생산 능력, 회사의 강점과 약점, 제품 출시, 제품 종류 및 범위, 응용 분야별 우위 등이 포함됩니다. 위에 제공된 데이터는 해당 회사의 시장 집중도와 관련된 데이터입니다.

생물학적 완충액 시장에서 활동하는 선두주자는 다음과 같습니다.

  • F. 호프만-라 로슈 유한회사(스위스)
  • Bio-Rad Laboratories, Inc. (미국)
  • Thermo Fisher Scientific Inc.(미국)
  • Takara Bio Inc.(일본), Merck KGaA(독일)
  • 아반터 주식회사(미국)
  • Advancion Corporation(미국)
  • 산타크루즈 바이오테크놀로지(미국)
  • MP 바이오메디컬스(미국)
  • 프로메가 코퍼레이션(미국)
  • Beckman Coulter, Inc.(미국)
  • QIAGEN(독일)
  • HiMedia Laboratories(인도)
  • 케이맨 케미컬(미국)
  • 바이오신스(스위스)
  • SERVA 전기영동 GmbH(독일)
  • 후지필름 와코 퓨어 케미컬 주식회사(일본)
  • Reagecon Diagnostics Ltd(아일랜드)
  • 골드바이오(미국)
  • nacalai.com(일본)
  • HOPAX(대만)

생물학적 완충액 시장의 최신 동향

  • 2024년 2월, 로슈는 PathAI와 협력 계약을 체결하여 동반 진단을 위한 디지털 병리학 역량을 확장했습니다. 이 협력을 통해 로슈는 PathAI의 첨단 AI 기술을 활용하여 동반 진단을 개선할 수 있게 되었습니다. 이를 통해 로슈는 독점적이고 맞춤형 솔루션을 확보하고 알고리즘 개발을 가속화하는 동시에 자체 진단 개발을 지속할 수 있게 되었습니다.
  • 2024년 7월, 로슈는 반독점법 및 규제 당국의 승인을 거쳐 루미라Dx의 현장진료(Point of Care) 기술 인수를 성공적으로 발표했습니다. 이 통합을 통해 다양한 면역검사 및 임상화학 검사를 통합하는 사용자 친화적인 플랫폼을 통해 로슈의 진단 포트폴리오가 강화되었습니다. 이번 인수는 특히 1차 진료 및 서비스 취약 지역의 진단 검사 접근성을 개선하는 것을 목표로 했으며, 이는 분산형 의료 솔루션에 대한 로슈의 의지와 일맥상통합니다.
  • 2023년 7월, Bio-Rad와 QIAGEN은 특정 기술과 관련된 현재 진행 중인 분쟁을 해결하기 위한 특허 합의 및 교차 라이선스 계약을 발표했습니다. 이 파트너십을 통해 양사는 제품 포트폴리오를 강화하고 생명 과학 분야의 혁신을 가속화할 수 있게 되었으며, 궁극적으로 연구 및 진단 분야에서 첨단 기술과 향상된 솔루션에 대한 더 폭넓은 접근성을 제공함으로써 고객에게 혜택을 제공할 수 있게 되었습니다.
  • 2023년 5월 Thermo Fisher와 BRIN은 인도네시아의 연구 역량을 강화하기 위해 파트너십을 맺었으며, 현지 연구자들을 위한 생명 과학, 생명 공학 및 환경 연구 분야의 과학적 혁신과 협업을 발전시키는 데 중점을 두었습니다.

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL BIOLOGICAL BUFFERS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 GLOBAL BIOLOGICAL BUFFER MARKET: REGULATIONS

5.1 REGULATORY AUTHORITIES IN THE U.S.

5.2 REGULATORY SUBMISSIONS

5.3 INTERNATIONAL HARMONIZATION

5.4 EUROPE REGULATORY SCENARIO

5.5 REGULATORY SUBMISSIONS

5.6 INTERNATIONAL HARMONIZATION

5.7 JAPAN REGULATORY SCENARIO

5.8 REGULATORY SUBMISSIONS

5.9 INTERNATIONAL HARMONIZATION

5.1 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

 

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE OF CHRONIC DISEASES

6.1.2 INCREASED ADOPTION OF WESTERN BLOT AND ELISA TECHNIQUES

6.1.3 TECHNOLOGICAL ADVANCEMENTS IN ASSAY DEVELOPMENT

6.1.4 ADVANCEMENTS IN PROTEOMICS AND GENOMICS

6.2 RESTRAINTS

6.2.1 LIMITED SHELF LIFE OF BLOCKING BUFFERS

6.2.2 POTENTIAL OF CONTAMINATION OR BATCH INCONSISTENCIES FOR BIOLOGICAL BUFFERS

6.3 OPPORTUNITY

6.3.1 INCREASE IN PUBLIC-PRIVATE FUNDING IN BIOMEDICAL RESEARCH

6.3.2 ANALYTICAL METHODS FOR FOOD SAFETY AND ENVIRONMENTAL TESTING.

6.3.3 DIAGNOSTIC AND CLINICAL APPLICATIONS USE BLOCKING BUFFERS.

6.4 CHALLENGES

6.4.1 ALTERNATIVE TECHNOLOGIES AND APPROACHES FOR INHIBITING BIOLOGICAL BUFFERS.

6.4.2 DISRUPTIONS IN THE SUPPLY CHAIN OF BIOLOGICAL BUFFERS.

7 GLOBAL BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE

7.1 OVERVIEW

7.2 GOODS BUFFERS

7.2.1 TRIS BUFFERS

7.2.2 HEPES BUFFERS

7.2.3 MOPS BUFFERS

7.2.4 MES BUFFERS

7.2.5 BIS-TRIS BUFFERS

7.3 OTHER SALT-BASED BUFFERS

7.3.1 PHOSPHATE BUFFERS

7.3.2 ACETATE BUFFERS

7.3.3 CITRATE BUFFERS

7.3.4 AMINO ACID BUFFERS

8 GLOBAL BIOLOGICAL BUFFERS MARKET, BY FORMULATION

8.1 OVERVIEW

8.2 POWDER

8.3 LIQUID

9 GLOBAL BIOLOGICAL BUFFERS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 PHARMACEUTICAL & BIOPHARMACEUTICALS

9.3 CELL CULTURE & MOLECULAR BIOLOGY

9.4 CLINICAL & DIAGNOSTIC APPLICATIONS

9.5 CHEMICAL & INDUSTRIAL APPLICATIONS

9.6 OTHERS

10 GLOBAL BIOLOGICAL BUFFERS MARKET, BY END USER

10.1 OVERVIEW

10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES

10.3 BIOTECHNOLOGY COMPANIES

10.4 RESEARCH & ACADEMIC INSTITUTES

10.5 DIAGNOSTIC LABORATORIES

10.6 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CMOS

11 GLOBAL BIOLOGICAL BUFFERS MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 U.S

11.2.2 CANADA

11.2.3 MEXICO

11.3 EUROPE

11.3.1 GERMANY

11.3.2 U.K

11.3.3 FRANCE

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 RUSSIA

11.3.7 SWITZERLAND

11.3.8 TURKEY

11.3.9 AUSTRIA

11.3.10 POLAND

11.3.11 IRELAND

11.3.12 NORWAY

11.3.13 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 JAPAN

11.4.2 CHINA

11.4.3 SOUTH KOREA

11.4.4 INDIA

11.4.5 SINGAPORE

11.4.6 THAILAND

11.4.7 INDONESIA

11.4.8 MALAYSIA

11.4.9 PHILIPPINES

11.4.10 AUSTRALIA

11.4.11 NEW ZEALAND

11.4.12 TAIWAN

11.4.13 REST OF ASIA-PACIFIC

11.5 MIDDLE EAST AND AFRICA

11.5.1 SOUTH AFRICA

11.5.2 SAUDI ARABIA

11.5.3 UAE

11.5.4 EGYPT

11.5.5 KUWAIT

11.5.6 ISRAEL

11.5.7 REST OF MIDDLE EAST AND AFRICA

11.6 SOUTH AMERICA

11.6.1 BRAZIL

11.6.2 ARGENTINA

11.6.3 CHILE

11.6.4 PERU

11.6.5 REST OF SOUTH AMERICA

12 GLOBAL BIOLOGICAL BUFFERS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: GLOBAL

12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

12.3 COMPANY SHARE ANALYSIS: EUROPE

12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT

14 COMPANY PROFILES

14.1 F. HOFFMANN-LA ROCHE LTD

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT UPDATES

14.2 BIO-RAD LABORATORIES, INC.

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.3 THERMO FISHER SCIENTIFIC, INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT UPDATES

14.4 TAKARA BIO INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 MERCK KGAA, DARMSTADT, GERMANY

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENTS

14.6 ADVANCION CORPORATION

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 AVANTOR, INC.

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 BECKMAN COULTER

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 BIOSYNTH

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.1 FUJIFILM WAKO PURE CHEMICAL CORPORATION

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 GOLDBIO

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 HOPAX

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENT

14.13 HIMEDIA LABORATORIES

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 MP BIOMEDICALS.

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 NACALAI TESQUE, INC.

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.16 PROMEGA CORPORATION

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENT

14.17 QIAGEN

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENT

14.18 REAGECON DIAGNOSTICS LTD

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 SANTA CRUZ BIOTECHNOLOGY INC.

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.2 SERVA ELECTROPHORESIS GMBH

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 TEVA PHARMACEUTICALS USA, INC.

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

표 목록

TABLE 1 GLOBAL BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 2 GLOBAL GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 3 GLOBAL GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 4 GLOBAL TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 5 GLOBAL HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND

TABLE 6 GLOBAL MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 7 GLOBAL MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 8 GLOBAL BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 9 GLOBAL OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 10 GLOBAL OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 11 GLOBAL PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 12 GLOBAL ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 13 GLOBAL CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 14 GLOBAL AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 15 GLOBAL BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 16 GLOBAL POWDER IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 17 GLOBAL LIQUID IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 18 GLOBAL BIOLOGICAL BUFFERS MARKET, BY APPLICATION,2018-2035 (USD THOUSAND)

TABLE 19 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 20 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 21 GLOBAL CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 22 GLOBAL CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 23 GLOBAL CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 24 GLOBAL CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 25 GLOBAL CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 26 GLOBAL CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 27 GLOBAL OTHERS IN BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 28 GLOBAL BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 29 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 30 GLOBAL BIOTECHNOLOGY COMPANIES IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 31 GLOBAL RESEARCH & ACADEMIC INSTITUTES IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2035 (USD THOUSAND)

TABLE 32 GLOBAL DIAGNOSTIC LABORATORIES IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 33 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ORTHODONTIC SUPPLIES MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 34 GLOBAL BIOLOGICAL BUFFERS MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 35 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY COUNTRY, 2018-2035 (USD THOUSAND)

TABLE 36 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 37 NORTH AMERICA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 38 NORTH AMERICA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 39 NORTH AMERICA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 40 NORTH AMERICA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 41 NORTH AMERICA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 42 NORTH AMERICA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 43 NORTH AMERICA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 44 NORTH AMERICA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 45 NORTH AMERICA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 46 NORTH AMERICA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 47 NORTH AMERICA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 48 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 49 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 50 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 51 NORTH AMERICA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 52 NORTH AMERICA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 53 NORTH AMERICA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 54 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 55 U.S. BIOLOGICAL BUFFER MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 56 U.S. GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 57 U.S. TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 58 U.S. HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 59 U.S. MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 60 U.S. MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 61 U.S. BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 62 U.S. OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 63 U.S. PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 64 U.S. ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 65 U.S. CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 66 U.S. AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 67 U.S. BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 68 U.S. BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 69 U.S. PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 70 U.S. CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 71 U.S. CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 72 U.S. CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 73 U.S. BIOLOGICAL BUFFER MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 74 CANADA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 75 CANADA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 76 CANADA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 77 CANADA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 78 CANADA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 79 CANADA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 80 CANADA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 81 CANADA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 82 CANADA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 83 CANADA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 84 CANADA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 85 CANADA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 86 CANADA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 87 CANADA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 88 CANADA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 89 CANADA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 90 CANADA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 91 CANADA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 92 CANADA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 93 MEXICO BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 94 MEXICO GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 95 MEXICO TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 96 MEXICO HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 97 MEXICO MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 98 MEXICO MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 99 MEXICO BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 100 MEXICO OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 101 MEXICO PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 102 MEXICO ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 103 MEXICO CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 104 MEXICO AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 105 MEXICO BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 106 MEXICO BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 107 MEXICO PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 108 MEXICO CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 109 MEXICO CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 110 MEXICO CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 111 MEXICO BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 112 EUROPE BIOLOGICAL BUFFERS MARKET, BY COUNTRY, 2018-2035 (USD THOUSAND)

TABLE 113 EUROPE BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 114 EUROPE GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 115 EUROPE TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 116 EUROPE HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 117 EUROPE MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 118 EUROPE MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 119 EUROPE BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 120 EUROPE OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 121 EUROPE PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 122 EUROPE ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 123 EUROPE CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 124 EUROPE AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 125 EUROPE BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 126 EUROPE BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 127 EUROPE PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 128 EUROPE CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 129 EUROPE CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 130 EUROPE CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 131 EUROPE BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 132 GERMANY BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 133 GERMANY GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 134 GERMANY TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 135 GERMANY HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 136 GERMANY MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 137 GERMANY MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 138 GERMANY BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 139 GERMANY OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 140 GERMANY PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 141 GERMANY ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 142 GERMANY CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 143 GERMANY AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 144 GERMANY BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 145 GERMANY BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 146 GERMANY PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 147 GERMANY CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 148 GERMANY CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 149 GERMANY CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 150 GERMANY BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 151 U.K. BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 152 U.K. GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 153 U.K. TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 154 U.K. HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 155 U.K. MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 156 U.K. MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 157 U.K. BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 158 U.K. OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 159 U.K. PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 160 U.K. ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 161 U.K. CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 162 U.K. AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 163 U.K. BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 164 U.K. BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 165 U.K. PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 166 U.K. CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 167 U.K. CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 168 U.K. CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 169 U.K. BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 170 FRANCE BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 171 FRANCE GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 172 FRANCE TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 173 FRANCE HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 174 FRANCE MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 175 FRANCE MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 176 FRANCE BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 177 FRANCE OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 178 FRANCE PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 179 FRANCE ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 180 FRANCE CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 181 FRANCE AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 182 FRANCE BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 183 FRANCE BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 184 FRANCE PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 185 FRANCE CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 186 FRANCE CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 187 FRANCE CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 188 FRANCE BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 189 ITALY BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 190 ITALY GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 191 ITALY TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 192 ITALY HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 193 ITALY MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 194 ITALY MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 195 ITALY BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 196 ITALY OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 197 ITALY PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 198 ITALY ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 199 ITALY CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 200 ITALY AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 201 ITALY BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 202 ITALY BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 203 ITALY PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 204 ITALY CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 205 ITALY CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 206 ITALY CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 207 ITALY BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 208 SPAIN BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 209 SPAIN GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 210 SPAIN TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 211 SPAIN HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 212 SPAIN MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 213 SPAIN MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 214 SPAIN BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 215 SPAIN OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 216 SPAIN PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 217 SPAIN ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 218 SPAIN CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 219 SPAIN AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 220 SPAIN BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 221 SPAIN BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 222 SPAIN PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 223 SPAIN CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 224 SPAIN CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 225 SPAIN CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 226 SPAIN BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 227 RUSSIA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 228 RUSSIA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 229 RUSSIA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 230 RUSSIA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 231 RUSSIA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 232 RUSSIA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 233 RUSSIA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 234 RUSSIA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 235 RUSSIA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 236 RUSSIA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 237 RUSSIA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 238 RUSSIA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 239 RUSSIA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 240 RUSSIA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 241 RUSSIA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 242 RUSSIA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 243 RUSSIA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 244 RUSSIA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 245 RUSSIA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 246 NETHERLAND

TABLE 247 NETHERLANDS BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 248 NETHERLANDS GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 249 NETHERLANDS TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 250 NETHERLANDS HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 251 NETHERLANDS MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 252 NETHERLANDS MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 253 NETHERLANDS BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 254 NETHERLANDS OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 255 NETHERLANDS PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 256 NETHERLANDS ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 257 NETHERLANDS CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 258 NETHERLANDS AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 259 NETHERLANDS BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 260 NETHERLANDS BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 261 NETHERLANDS PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 262 NETHERLANDS CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 263 NETHERLANDS CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 264 NETHERLANDS CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 265 NETHERLANDS BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 266 SWITZERLAND BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 267 SWITZERLAND GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 268 SWITZERLAND TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 269 SWITZERLAND HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 270 SWITZERLAND MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 271 SWITZERLAND MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 272 SWITZERLAND BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 273 SWITZERLAND OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 274 SWITZERLAND PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 275 SWITZERLAND ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 276 SWITZERLAND CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 277 SWITZERLAND AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 278 SWITZERLAND BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 279 SWITZERLAND BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 280 SWITZERLAND PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 281 SWITZERLAND CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 282 SWITZERLAND CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 283 SWITZERLAND CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 284 SWITZERLAND BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 285 TURKEY BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 286 TURKEY GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 287 TURKEY TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 288 TURKEY HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 289 TURKEY MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 290 TURKEY MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 291 TURKEY BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 292 TURKEY OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 293 TURKEY PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 294 TURKEY ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 295 TURKEY CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 296 TURKEY AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 297 TURKEY BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 298 TURKEY BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 299 TURKEY PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 300 TURKEY CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 301 TURKEY CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 302 TURKEY CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 303 TURKEY BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 304 AUSTRIA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 305 AUSTRIA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 306 AUSTRIA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 307 AUSTRIA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 308 AUSTRIA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 309 AUSTRIA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 310 AUSTRIA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 311 AUSTRIA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 312 AUSTRIA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 313 AUSTRIA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 314 AUSTRIA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 315 AUSTRIA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 316 AUSTRIA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 317 AUSTRIA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 318 AUSTRIA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 319 AUSTRIA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 320 AUSTRIA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 321 AUSTRIA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 322 AUSTRIA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 323 POLAND BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 324 POLAND GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 325 POLAND TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 326 POLAND HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 327 POLAND MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 328 POLAND MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 329 POLAND BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 330 POLAND OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 331 POLAND PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 332 POLAND ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 333 POLAND CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 334 POLAND AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 335 POLAND BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 336 POLAND BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 337 POLAND PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 338 POLAND CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 339 POLAND CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 340 POLAND CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 341 POLAND BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 342 IRELAND BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 343 IRELAND GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 344 IRELAND TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 345 IRELAND HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 346 IRELAND MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 347 IRELAND MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 348 IRELAND BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 349 IRELAND OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 350 IRELAND PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 351 IRELAND ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 352 IRELAND CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 353 IRELAND AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 354 IRELAND BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 355 IRELAND BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 356 IRELAND PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 357 IRELAND CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 358 IRELAND CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 359 IRELAND CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 360 IRELAND BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 361 NORWAY BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 362 NORWAY GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 363 NORWAY TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 364 NORWAY HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 365 NORWAY MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 366 NORWAY MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 367 NORWAY BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 368 NORWAY OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 369 NORWAY PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 370 NORWAY ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 371 NORWAY CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 372 NORWAY AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 373 NORWAY BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 374 NORWAY BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 375 NORWAY PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 376 NORWAY CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 377 NORWAY CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 378 NORWAY CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 379 NORWAY BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 380 REST OF EUROPE BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 381 ASIA-PACIFIC BIOLOGICAL BUFFERS MARKET, BY COUNTRY, 2018-2035 (USD THOUSAND)

TABLE 382 ASIA-PACIFIC BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 383 ASIA-PACIFIC GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 384 ASIA-PACIFIC TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 385 ASIA-PACIFIC HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 386 ASIA-PACIFIC MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 387 ASIA-PACIFIC MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 388 ASIA-PACIFIC BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 389 ASIA-PACIFIC OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 390 ASIA-PACIFIC PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 391 ASIA-PACIFIC ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 392 ASIA-PACIFIC CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 393 ASIA-PACIFIC AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 394 ASIA-PACIFIC BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 395 ASIA-PACIFIC BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 396 ASIA-PACIFIC PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 397 ASIA-PACIFIC CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 398 ASIA-PACIFIC CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 399 ASIA-PACIFIC CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 400 ASIA-PACIFIC BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 401 JAPAN BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 402 JAPAN GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 403 JAPAN TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 404 JAPAN HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 405 JAPAN MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 406 JAPAN MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 407 JAPAN BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 408 JAPAN OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 409 JAPAN PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 410 JAPAN ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 411 JAPAN CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 412 JAPAN AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 413 JAPAN BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 414 JAPAN BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 415 JAPAN PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 416 JAPAN CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 417 JAPAN CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 418 JAPAN CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 419 JAPAN BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 420 CHINA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 421 CHINA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 422 CHINA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 423 CHINA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 424 CHINA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 425 CHINA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 426 CHINA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 427 CHINA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 428 CHINA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 429 CHINA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 430 CHINA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 431 CHINA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 432 CHINA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 433 CHINA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 434 CHINA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 435 CHINA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 436 CHINA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 437 CHINA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 438 CHINA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 439 SOUTH KOREA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 440 SOUTH KOREA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 441 SOUTH KOREA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 442 SOUTH KOREA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 443 SOUTH KOREA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 444 SOUTH KOREA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 445 SOUTH KOREA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 446 SOUTH KOREA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 447 SOUTH KOREA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 448 SOUTH KOREA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 449 SOUTH KOREA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 450 SOUTH KOREA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 451 SOUTH KOREA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 452 SOUTH KOREA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 453 SOUTH KOREA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 454 SOUTH KOREA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 455 SOUTH KOREA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 456 SOUTH KOREA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 457 SOUTH KOREA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 458 INDIA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 459 INDIA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 460 INDIA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 461 INDIA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 462 INDIA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 463 INDIA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 464 INDIA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 465 INDIA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 466 INDIA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 467 INDIA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 468 INDIA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 469 INDIA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 470 INDIA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 471 INDIA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 472 INDIA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 473 INDIA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 474 INDIA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 475 INDIA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 476 INDIA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 477 SINGAPORE BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 478 SINGAPORE GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 479 SINGAPORE TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 480 SINGAPORE HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 481 SINGAPORE MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 482 SINGAPORE MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 483 SINGAPORE BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 484 SINGAPORE OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 485 SINGAPORE PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 486 SINGAPORE ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 487 SINGAPORE CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 488 SINGAPORE AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 489 SINGAPORE BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 490 SINGAPORE BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 491 SINGAPORE PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 492 SINGAPORE CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 493 SINGAPORE CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 494 SINGAPORE CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 495 SINGAPORE BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 496 THAILAND BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 497 THAILAND GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 498 THAILAND TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 499 THAILAND HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 500 THAILAND MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 501 THAILAND MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 502 THAILAND BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 503 THAILAND OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 504 THAILAND PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 505 THAILAND ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 506 THAILAND CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 507 THAILAND AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 508 THAILAND BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 509 THAILAND BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 510 THAILAND PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 511 THAILAND CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 512 THAILAND CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 513 THAILAND CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 514 THAILAND BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 515 INDONESIA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 516 INDONESIA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 517 INDONESIA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 518 INDONESIA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 519 INDONESIA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 520 INDONESIA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 521 INDONESIA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 522 INDONESIA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 523 INDONESIA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 524 INDONESIA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 525 INDONESIA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 526 INDONESIA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 527 INDONESIA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 528 INDONESIA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 529 INDONESIA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 530 INDONESIA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 531 INDONESIA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 532 INDONESIA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 533 INDONESIA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 534 MALAYSIA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 535 MALAYSIA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 536 MALAYSIA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 537 MALAYSIA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 538 MALAYSIA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 539 MALAYSIA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 540 MALAYSIA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 541 MALAYSIA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 542 MALAYSIA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 543 MALAYSIA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 544 MALAYSIA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 545 MALAYSIA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 546 MALAYSIA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 547 MALAYSIA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 548 MALAYSIA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 549 MALAYSIA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 550 MALAYSIA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 551 MALAYSIA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 552 MALAYSIA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 553 PHILIPPINES BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 554 PHILIPPINES GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 555 PHILIPPINES TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 556 PHILIPPINES HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 557 PHILIPPINES MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 558 PHILIPPINES MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 559 PHILIPPINES BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 560 PHILIPPINES OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 561 PHILIPPINES PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 562 PHILIPPINES ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 563 PHILIPPINES CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 564 PHILIPPINES AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 565 PHILIPPINES BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 566 PHILIPPINES BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 567 PHILIPPINES PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 568 PHILIPPINES CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 569 PHILIPPINES CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 570 PHILIPPINES CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 571 PHILIPPINES BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 572 AUSTRALIA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 573 AUSTRALIA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 574 AUSTRALIA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 575 AUSTRALIA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 576 AUSTRALIA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 577 AUSTRALIA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 578 AUSTRALIA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 579 AUSTRALIA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 580 AUSTRALIA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 581 AUSTRALIA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 582 AUSTRALIA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 583 AUSTRALIA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 584 AUSTRALIA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 585 AUSTRALIA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 586 AUSTRALIA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 587 AUSTRALIA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 588 AUSTRALIA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 589 AUSTRALIA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 590 AUSTRALIA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 591 NEW ZEALAND BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 592 NEW ZEALAND GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 593 NEW ZEALAND TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 594 NEW ZEALAND HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 595 NEW ZEALAND MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 596 NEW ZEALAND MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 597 NEW ZEALAND BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 598 NEW ZEALAND OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 599 NEW ZEALAND PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 600 NEW ZEALAND ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 601 NEW ZEALAND CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 602 NEW ZEALAND AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 603 NEW ZEALAND BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 604 NEW ZEALAND BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 605 NEW ZEALAND PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 606 NEW ZEALAND CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 607 NEW ZEALAND CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 608 NEW ZEALAND CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 609 NEW ZEALAND BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 610 TAIWAN BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 611 TAIWAN GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 612 TAIWAN TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 613 TAIWAN HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 614 TAIWAN MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 615 TAIWAN MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 616 TAIWAN BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 617 TAIWAN OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 618 TAIWAN PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 619 TAIWAN ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 620 TAIWAN CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 621 TAIWAN AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 622 TAIWAN BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 623 TAIWAN BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 624 TAIWAN PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 625 TAIWAN CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 626 TAIWAN CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 627 TAIWAN CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 628 TAIWAN BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 629 REST OF ASIA-PACIFIC BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 630 MIDDLE EAST AND AFRICA BIOLOGICAL BUFFERS MARKET, BY COUNTRY, 2018-2035 (USD THOUSAND)

TABLE 631 MIDDLE EAST AND AFRICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 632 MIDDLE EAST AND AFRICA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 633 MIDDLE EAST AND AFRICA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 634 MIDDLE EAST AND AFRICA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 635 MIDDLE EAST AND AFRICA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 636 MIDDLE EAST AND AFRICA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 637 MIDDLE EAST AND AFRICA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 638 MIDDLE EAST AND AFRICA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 639 MIDDLE EAST AND AFRICA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 640 MIDDLE EAST AND AFRICA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 641 MIDDLE EAST AND AFRICA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 642 MIDDLE EAST AND AFRICA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 643 MIDDLE EAST AND AFRICA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 644 MIDDLE EAST AND AFRICA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 645 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 646 MIDDLE EAST AND AFRICA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 647 MIDDLE EAST AND AFRICA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 648 MIDDLE EAST AND AFRICA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 649 MIDDLE EAST AND AFRICA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 650 SOUTH AFRICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 651 SOUTH AFRICA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 652 SOUTH AFRICA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 653 SOUTH AFRICA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 654 SOUTH AFRICA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 655 SOUTH AFRICA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 656 SOUTH AFRICA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 657 SOUTH AFRICA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 658 SOUTH AFRICA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 659 SOUTH AFRICA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 660 SOUTH AFRICA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 661 SOUTH AFRICA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 662 SOUTH AFRICA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 663 SOUTH AFRICA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 664 SOUTH AFRICA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 665 SOUTH AFRICA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 666 SOUTH AFRICA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 667 SOUTH AFRICA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 668 SOUTH AFRICA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 669 SAUDI ARABIA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 670 SAUDI ARABIA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 671 SAUDI ARABIA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 672 SAUDI ARABIA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 673 SAUDI ARABIA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 674 SAUDI ARABIA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 675 SAUDI ARABIA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 676 SAUDI ARABIA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 677 SAUDI ARABIA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 678 SAUDI ARABIA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 679 SAUDI ARABIA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 680 SAUDI ARABIA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 681 SAUDI ARABIA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 682 SAUDI ARABIA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 683 SAUDI ARABIA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 684 SAUDI ARABIA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 685 SAUDI ARABIA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 686 SAUDI ARABIA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 687 SAUDI ARABIA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 688 UAE BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 689 UAE GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 690 UAE TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 691 UAE HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 692 UAE MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 693 UAE MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 694 UAE BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 695 UAE OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 696 UAE PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 697 UAE ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 698 UAE CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 699 UAE AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 700 UAE BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 701 UAE BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 702 UAE PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 703 UAE CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 704 UAE CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 705 UAE CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 706 UAE BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 707 EGYPT BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 708 EGYPT GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 709 EGYPT TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 710 EGYPT HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 711 EGYPT MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 712 EGYPT MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 713 EGYPT BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 714 EGYPT OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 715 EGYPT PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 716 EGYPT ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 717 EGYPT CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 718 EGYPT AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 719 EGYPT BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 720 EGYPT BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 721 EGYPT PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 722 EGYPT CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 723 EGYPT CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 724 EGYPT CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 725 EGYPT BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 726 KUWAIT BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 727 KUWAIT GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 728 KUWAIT TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 729 KUWAIT HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 730 KUWAIT MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 731 KUWAIT MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 732 KUWAIT BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 733 KUWAIT OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 734 KUWAIT PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 735 KUWAIT ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 736 KUWAIT CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 737 KUWAIT AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 738 KUWAIT BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 739 KUWAIT BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 740 KUWAIT PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 741 KUWAIT CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 742 KUWAIT CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 743 KUWAIT CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 744 KUWAIT BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 745 ISRAEL BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 746 ISRAEL GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 747 ISRAEL TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 748 ISRAEL HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 749 ISRAEL MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 750 ISRAEL MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 751 ISRAEL BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 752 ISRAEL OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 753 ISRAEL PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 754 ISRAEL ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 755 ISRAEL CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 756 ISRAEL AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 757 ISRAEL BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 758 ISRAEL BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 759 ISRAEL PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 760 ISRAEL CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 761 ISRAEL CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 762 ISRAEL CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 763 ISRAEL BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 764 REST OF MIDDLE EAST AND AFRICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 765 SOUTH AMERICA BIOLOGICAL BUFFERS MARKET, BY COUNTRY, 2018-2035 (USD THOUSAND)

TABLE 766 SOUTH AMERICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 767 SOUTH AMERICA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 768 SOUTH AMERICA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 769 SOUTH AMERICA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 770 SOUTH AMERICA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 771 SOUTH AMERICA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 772 SOUTH AMERICA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 773 SOUTH AMERICA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 774 SOUTH AMERICA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 775 SOUTH AMERICA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 776 SOUTH AMERICA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 777 SOUTH AMERICA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 778 SOUTH AMERICA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 779 SOUTH AMERICA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 780 SOUTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 781 SOUTH AMERICA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 782 SOUTH AMERICA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 783 SOUTH AMERICA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 784 SOUTH AMERICA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 785 BRAZIL BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 786 BRAZIL GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 787 BRAZIL TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 788 BRAZIL HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 789 BRAZIL MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 790 BRAZIL MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 791 BRAZIL BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 792 BRAZIL OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 793 BRAZIL PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 794 BRAZIL ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 795 BRAZIL CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 796 BRAZIL AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 797 BRAZIL BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 798 BRAZIL BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 799 BRAZIL PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 800 BRAZIL CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 801 BRAZIL CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 802 BRAZIL CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 803 BRAZIL BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 804 ARGENTINA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 805 ARGENTINA GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 806 ARGENTINA TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 807 ARGENTINA HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 808 ARGENTINA MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 809 ARGENTINA MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 810 ARGENTINA BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 811 ARGENTINA OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 812 ARGENTINA PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 813 ARGENTINA ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 814 ARGENTINA CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 815 ARGENTINA AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 816 ARGENTINA BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 817 ARGENTINA BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 818 ARGENTINA PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 819 ARGENTINA CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 820 ARGENTINA CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 821 ARGENTINA CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 822 ARGENTINA BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 823 CHILE BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 824 CHILE GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 825 CHILE TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 826 CHILE HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 827 CHILE MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 828 CHILE MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 829 CHILE BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 830 CHILE OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 831 CHILE PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 832 CHILE ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 833 CHILE CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 834 CHILE AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 835 CHILE BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 836 CHILE BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 837 CHILE PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 838 CHILE CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 839 CHILE CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 840 CHILE CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 841 CHILE BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 842 PERU BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

TABLE 843 PERU GOODS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 844 PERU TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 845 PERU HEPES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 846 PERU MOPS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 847 PERU MES BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 848 PERU BIS-TRIS BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TREATMENT TYPE, 2018-2035 (USD THOUSAND)

TABLE 849 PERU OTHER SALT-BASED BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 850 PERU PHOSPHATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 851 PERU ACETATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 852 PERU CITRATE BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 853 PERU AMINO ACID BUFFERS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 854 PERU BIOLOGICAL BUFFERS MARKET, BY FORMULATION, 2018-2035 (USD THOUSAND)

TABLE 855 PERU BIOLOGICAL BUFFERS MARKET, BY APPLICATION, 2018-2035 (USD THOUSAND)

TABLE 856 PERU PHARMACEUTICAL & BIOPHARMACEUTICALS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 857 PERU CELL CULTURE & MOLECULAR BIOLOGY IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 858 PERU CLINICAL & DIAGNOSTIC APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 859 PERU CHEMICAL & INDUSTRIAL APPLICATIONS IN BIOLOGICAL BUFFERS MARKET, BY TYPE, 2018-2035 (USD THOUSAND)

TABLE 860 PERU BIOLOGICAL BUFFERS MARKET, BY END USER, 2018-2035 (USD THOUSAND)

TABLE 861 REST OF SOUTH AMERICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE, 2018-2035 (USD THOUSAND)

그림 목록

FIGURE 1 GLOBAL BIOLOGICAL BUFFERS MARKET: SEGMENTATION

FIGURE 2 GLOBAL BIOLOGICAL BUFFERS MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL BIOLOGICAL BUFFERS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL BIOLOGICAL BUFFERS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL BIOLOGICAL BUFFERS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL BIOLOGICAL BUFFERS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL BIOLOGICAL BUFFERS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL BIOLOGICAL BUFFERS MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 GLOBAL BIOLOGICAL BUFFERS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL BIOLOGICAL BUFFERS MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GLOBAL BIOLOGICAL BUFFERS MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2035

FIGURE 12 GOODS BUFFERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL BIOLOGICAL BUFFERS MARKET IN THE FORECAST PERIOD OF 2025 & 2035

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL BIOLOGICAL BUFFERS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2035

FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL BIOLOGICAL BUFFERS MARKET IN THE FORECAST PERIOD OF 2025 TO 2035

FIGURE 15 GLOBAL BIOLOGICAL BUFFERS MARKET EXECUTIVE SUMMARY

FIGURE 16 STRATEGIC DECISIONS

FIGURE 17 DROC

FIGURE 18 GLOBAL BIOLOGICAL BUFFERS MARKET: BY BUFFER TYPE, 2024

FIGURE 19 GLOBAL BIOLOGICAL BUFFERS MARKET: BY BUFFER TYPE, 2025-2035 (USD THOUSAND)

FIGURE 20 GLOBAL BIOLOGICAL BUFFERS MARKET: BY BUFFER TYPE, CAGR (2025-2035)

FIGURE 21 GLOBAL BIOLOGICAL BUFFERS MARKET: BY BUFFER TYPE, LIFELINE CURVE

FIGURE 22 GLOBAL BIOLOGICAL BUFFERS MARKET: BY FORMULATION, 2024

FIGURE 23 GLOBAL BIOLOGICAL BUFFERS MARKET: BY FORMULATION, 2025-2035 (USD THOUSAND)

FIGURE 24 GLOBAL BIOLOGICAL BUFFERS MARKET: BY FORMULATION, CAGR (2025-2035)

FIGURE 25 GLOBAL BIOLOGICAL BUFFERS MARKET: BY FORMULATION, LIFELINE CURVE

FIGURE 26 GLOBAL BIOLOGICAL BUFFERS MARKET: BY APPLICATION, 2024

FIGURE 27 GLOBAL BIOLOGICAL BUFFERS MARKET: BY APPLICATION, 2025-2035 (USD THOUSAND)

FIGURE 28 GLOBAL BIOLOGICAL BUFFERS MARKET: BY APPLICATION, CAGR (2025-2035)

FIGURE 29 GLOBAL BIOLOGICAL BUFFERS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 GLOBAL BIOLOGICAL BUFFERS MARKET: BY END USER, 2024

FIGURE 31 GLOBAL BIOLOGICAL BUFFERS MARKET: BY END USER, 2025-2035 (USD THOUSAND)

FIGURE 32 GLOBAL BIOLOGICAL BUFFERS MARKET: BY END USER, CAGR (2025-2035)

FIGURE 33 GLOBAL BIOLOGICAL BUFFERS MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 GLOBAL BIOLOGICAL BUFFERS MARKET: SNAPSHOT (2024)

FIGURE 35 GLOBAL BIOLOGICAL BUFFERS MARKET: COMPANY SHARE 2024 (%)

FIGURE 36 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: COMPANY SHARE 2024 (%)

FIGURE 37 EUROPE BIOLOGICAL BUFFERS MARKET: COMPANY SHARE 2024 (%)

FIGURE 38 ASIA-PACIFIC BIOLOGICAL BUFFERS MARKET: COMPANY SHARE 2024 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

시장은 글로벌 생물학적 완충액 시장 세분화, 완충액 유형(제품 완충액 및 기타 염 기반 완충액), 제형(분말 및 액상), 응용 분야(제약 및 생물약학, 세포 배양 및 분자 생물학, 임상 및 진단 응용 분야, 화학 및 산업 응용 분야, 기타), 최종 사용자(제약 및 생물약학 회사, 생명공학 회사, 연구 및 학술 기관, 진단 실험실, 임상시험수탁기관(CRO) 및 CMO) - 2035년까지의 산업 동향 및 전망 기준으로 세분화됩니다.
글로벌 생물학적 완충액 시장의 시장 규모는 2024년에 1850.91 USD Million USD로 평가되었습니다.
글로벌 생물학적 완충액 시장는 2025년부터 2035년까지 연평균 성장률(CAGR) 7.5%로 성장할 것으로 예상됩니다.
시장 내 주요 기업으로는 F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Takara Bio Inc., Merck KGaA가 포함됩니다.

관련 페이지 탐색

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future